RARE
Ultragenyx PharmaceuticalANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
RARE vs peer average
76/100
RARE vs. peer average (A vs. C)
Grade spread
A 2 · B 3 · D 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
BCRX is the first available peer comparator.
Same-sector, similar-market-cap screening peer at approximately $2.54 billion; operating and indication comparability is not validated in the packet.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RARE
Ultragenyx Pharmaceutical
BCRX
BioCryst
Grade
A
A
Momentum
2
36
Value
41
71
Sentiment
91
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs BCRX
RARE / BCRX
Grade Position
Above peers
RARE vs. peer average (A vs. C)
76/100
Momentum
2
BCRXValue
41
BCRXSentiment
91
BCRXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RARE
BCRX is the first peer returned for this comparison set.